Geraldine O’Sullivan Coyne

Company: National Cancer Institute

Job title: Staff Clinician, Developmental Therapeutics Clinic

Seminars:

Live Presenter Q&A 3:05 pm

Ask the speakers your most burning questions!Read more

day: Day Two

Phase I Study of Recombinant Human Interleukin 15 (rhIL-15) in Combination with Checkpoint Inhibitors Nivolumab and Ipilimumab in Subjects with Advanced Solid Tumours 2:05 pm

Will discuss pre-clinical data and biological rationale for developing a clinical trial evaluating the combination of recombinant human interleuking-15 with immune checkpoint inhibitors Discussion of preliminary safety data and clinical activity for the combination Brief overview of the biomarker evaluation for this combinationRead more

day: Day Two